IDO1 and metabolic syndrome: The majority of available studies suggest that most symptoms of MetS are associated with a decline in IDO activity, an increased production of proinflammatory cytokines, especially IFNγ, and a higher incidence of highly productive alleles of the genes contributing to proinflammatory cytokines production [13].